Development
Semler Scientific, Inc.
SMLR
$30.25
-$1.18-3.75%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 20.28% | 22.94% | 18.90% | 13.03% | 6.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.28% | 22.94% | 18.90% | 13.03% | 6.90% |
| Cost of Revenue | 64.21% | -8.69% | -12.26% | -17.43% | -30.53% |
| Gross Profit | 16.72% | 26.31% | 22.39% | 16.50% | 11.79% |
| SG&A Expenses | 6.63% | 9.90% | 13.52% | 17.66% | 28.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.46% | 9.80% | 12.64% | 13.34% | 17.57% |
| Operating Income | 33.64% | 56.57% | 33.81% | 12.37% | -11.53% |
| Income Before Tax | 36.23% | 63.49% | 42.00% | 17.28% | -9.07% |
| Income Tax Expenses | 4.48% | 100.57% | 70.26% | 165.71% | 50.72% |
| Earnings from Continuing Operations | 43.69% | 55.18% | 35.51% | 1.46% | -16.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.69% | 55.18% | 35.51% | 1.46% | -16.82% |
| EBIT | 33.64% | 56.57% | 33.81% | 12.37% | -11.53% |
| EBITDA | 32.67% | 54.63% | 33.48% | 12.58% | -10.73% |
| EPS Basic | 43.68% | 55.99% | 36.84% | 1.89% | -16.89% |
| Normalized Basic EPS | 44.14% | 69.62% | 44.75% | 18.46% | -9.10% |
| EPS Diluted | 46.88% | 59.15% | 38.81% | 3.55% | -16.01% |
| Normalized Diluted EPS | 46.91% | 72.39% | 46.99% | 20.50% | -7.53% |
| Average Basic Shares Outstanding | 0.08% | -0.59% | -1.01% | -0.60% | -0.06% |
| Average Diluted Shares Outstanding | -2.15% | -2.28% | -2.52% | -2.21% | -1.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |